Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-000170-30Phase 4Completed
Phase 4, randomised, double-blind trial in pain comparing Oxycodone, Venlafaxine and Placebo (3 arms). Primary endpoints: Changes in pain sensitivity measured by nociceptive withdrawal reflex, Changes in pain sensitivity measured by spinal evoked potentials and 1 more. Started Apr 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-000170-30.